Patent · US Expired

Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases

US7166609B2 · kind B2 · utility

3Cited by

2References

7Claims

0Family size

Assignee

Sanofi-Aventis Deutschland GMBH · DE

Inventors

Otmar Klingler · Rodgau, DE
Reinhard Kirsch · Braunschweig, DE
Joerg Habermann · Roma, IT
Klaus-Ulrich Weithmann · Hofheim, DE
Christian Engel · Frankfurt am Main, DE
Bernard Pirard · Basel, CH

Key dates

Filing date	Nov 3, 2003
Grant date	Jan 23, 2007
Priority date	—
Expiry date	Sep 22, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Pyrimidine-4,6-dicarboxylic acid diamides of the formula Iare suitable for selectively inhibiting collagenase (MMP 13). The pyrimidine-4,6-dicarboxylic acid diamides can therefore be used for treating degenerative joint diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.